Geode Capital Management, LLC Meridian Bioscience Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$31.15 - $33.39 $148,710 - $159,403	4,774 Added 0.55%	880,543 $29.2 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $449,038 - $487,548	14,532 Added 1.69%	875,769 $27.6 Million
Q2 2022 Aug 12, 2022	BUY	$23.75 - $31.69 $1.52 Million - $2.03 Million	63,959 Added 8.02%	861,237 $26.2 Million
Q1 2022 May 13, 2022	BUY	$19.97 - $26.94 $502,165 - $677,433	25,146 Added 3.26%	797,278 $20.7 Million
Q4 2021 Feb 11, 2022	SELL	$17.46 - $21.61 $988,078 - $1.22 Million	-56,591 Reduced 6.83%	772,132 $15.8 Million
Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $1.78 Million - $2.31 Million	-102,580 Reduced 11.01%	828,723 $15.9 Million
Q2 2021 Aug 13, 2021	BUY	$18.01 - $28.32 $416,139 - $654,361	23,106 Added 2.54%	931,303 $20.7 Million
Q1 2021 May 12, 2021	BUY	$19.76 - $29.89 $1.4 Million - $2.12 Million	70,973 Added 8.48%	908,197 $23.8 Million
Q4 2020 Feb 12, 2021	BUY	$15.73 - $21.66 $931,231 - $1.28 Million	59,201 Added 7.61%	837,224 $15.6 Million
Q3 2020 Nov 13, 2020	SELL	$13.54 - $26.41 $916,346 - $1.79 Million	-67,677 Reduced 8.0%	778,023 $13.2 Million
Q2 2020 Aug 13, 2020	SELL	$7.84 - $23.29 $298,515 - $886,790	-38,076 Reduced 4.31%	845,700 $19.7 Million
Q1 2020 May 14, 2020	BUY	$5.57 - $11.5 $119,654 - $247,043	21,482 Added 2.49%	883,776 $7.42 Million
Q4 2019 Feb 13, 2020	SELL	$7.9 - $10.14 $862,048 - $1.11 Million	-109,120 Reduced 11.23%	862,294 $8.42 Million
Q3 2019 Nov 12, 2019	BUY	$9.17 - $12.01 $778,102 - $1.02 Million	84,853 Added 9.57%	971,414 $9.22 Million
Q2 2019 Aug 14, 2019	BUY	$10.88 - $17.6 $507,443 - $820,864	46,640 Added 5.55%	886,561 $10.5 Million
Q1 2019 May 14, 2019	BUY	$15.51 - $17.61 $321,460 - $364,984	20,726 Added 2.53%	839,921 $14.8 Million
Q4 2018 Feb 13, 2019	SELL	$14.52 - $19.72 $162,914 - $221,258	-11,220 Reduced 1.35%	819,195 $14.2 Million
Q3 2018 Nov 13, 2018	BUY	$14.85 - $16.35 $332,550 - $366,141	22,394 Added 2.77%	830,415 $12.4 Million
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $971,285 - $1.18 Million	70,383 Added 9.54%	808,021 $12.8 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.2 $572,865 - $672,494	41,512 Added 5.96%	737,638 $10.5 Million
Q4 2017 Feb 13, 2018	BUY	$13.55 - $15.8 $1.77 Million - $2.07 Million	130,722 Added 23.12%	696,126 $9.74 Million
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $918,070 - $979,502	68,258 Added 13.73%	565,404 $8.09 Million
Q2 2017 Aug 14, 2017	BUY	N/A	497,146	497,146 $7.83 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account